-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 06/12/23 )
NAV
₹104.45
Last change
₹-0.5 -0.0%
Fund Size (AUM)
6204.41 Cr
Performance
22.91% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 06/12/23
AUM
6204.41 Cr
Expense Ratio
1.88 %
Benchmark
S&P BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | 29.88% | 20.17% | 22.91% |
| S&P BSE Healthcare TR INR | 26.85% | 14.34% | 16.21% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.95% |
Lupin Ltd |
7.85% |
Cipla Ltd |
6.06% |
Apollo Hospitals Enterprise Ltd |
5.78% |
Dr Reddy's Laboratories Ltd |
5.13% |
Gland Pharma Ltd |
4.86% |
Divi's Laboratories Ltd |
4.58% |
Aurobindo Pharma Ltd |
4.2% |
Medplus Health Services Ltd |
3.95% |
Narayana Hrudayalaya Ltd |
3.65% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
22.91% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
22.91% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
20.17% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
20.17% (5Y)
-
-
Nippon India Pharma Gr
Equity healthcare-
Returns
-
20.51% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
23.3% (5Y)
-
